DMK Annual Accounts Payable
$7.94 M
+$4.18 M+111.44%
01 December 2022
Summary:
As of February 4, 2025, DMK annual accounts payable is $7.94 million, with the most recent change of +$4.18 million (+111.44%) on December 1, 2022. During the last 3 years, it has risen by +$3.67 million (+85.99%).DMK Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Quarterly Accounts Payable
$9.97 M
-$1.39 M-12.25%
01 September 2023
Summary:
As of February 4, 2025, DMK quarterly accounts payable is $9.97 million, with the most recent change of -$1.39 million (-12.25%) on September 1, 2023. Over the past year, it has increased by +$4.68 million (+88.26%).DMK Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DMK Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.4% | +88.3% |
| 3 y3 years | +86.0% | +221.6% |
| 5 y5 years | +171.9% | +188.5% |
DMK Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -12.3% |
DMK Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $9.97 M(-12.3%) |
| June 2023 | - | $11.37 M(+16.2%) |
| Mar 2023 | - | $9.78 M(+23.2%) |
| Dec 2022 | $7.94 M(+111.4%) | $7.94 M(+49.8%) |
| Sept 2022 | - | $5.30 M(+17.3%) |
| June 2022 | - | $4.52 M(-7.7%) |
| Mar 2022 | - | $4.89 M(+30.3%) |
| Dec 2021 | $3.75 M(+110.9%) | $3.75 M(+53.0%) |
| Sept 2021 | - | $2.45 M(-18.5%) |
| June 2021 | - | $3.01 M(-25.4%) |
| Mar 2021 | - | $4.04 M(+126.7%) |
| Dec 2020 | $1.78 M(-58.3%) | $1.78 M(-42.6%) |
| Sept 2020 | - | $3.10 M(-27.3%) |
| June 2020 | - | $4.26 M(+25.1%) |
| Mar 2020 | - | $3.41 M(-20.1%) |
| Dec 2019 | $4.27 M(+2.3%) | $4.27 M(+27.7%) |
| Sept 2019 | - | $3.34 M(-21.7%) |
| June 2019 | - | $4.27 M(+6.4%) |
| Mar 2019 | - | $4.01 M(-3.7%) |
| Dec 2018 | $4.17 M(+42.9%) | $4.17 M(+20.6%) |
| Sept 2018 | - | $3.46 M(-33.1%) |
| June 2018 | - | $5.16 M(+121.5%) |
| Mar 2018 | - | $2.33 M(-20.1%) |
| Dec 2017 | $2.92 M(+35.7%) | $2.92 M(+66.8%) |
| Sept 2017 | - | $1.75 M(-7.6%) |
| June 2017 | - | $1.89 M(-30.2%) |
| Mar 2017 | - | $2.71 M(+26.2%) |
| Dec 2016 | $2.15 M(+332.0%) | $2.15 M(+25.8%) |
| Sept 2016 | - | $1.71 M(-59.0%) |
| June 2016 | - | $4.17 M(+176.4%) |
| Mar 2016 | - | $1.51 M(+203.3%) |
| Dec 2015 | $497.80 K(-36.7%) | $497.80 K(+21.8%) |
| Sept 2015 | - | $408.80 K(-17.9%) |
| June 2015 | - | $498.00 K(-49.0%) |
| Mar 2015 | - | $977.20 K(+30.3%) |
| Dec 2014 | $787.00 K(+17.3%) | - |
| Sept 2014 | - | $750.00 K(+36.9%) |
| June 2014 | - | $547.70 K(-18.4%) |
| Mar 2014 | $671.00 K(-72.4%) | $671.00 K(-60.7%) |
| Dec 2013 | - | $1.71 M(-26.9%) |
| Sept 2013 | - | $2.34 M(+12.4%) |
| June 2013 | - | $2.08 M(-14.5%) |
| Mar 2013 | $2.43 M(+20.3%) | $2.43 M(+25.3%) |
| Dec 2012 | - | $1.94 M(+5.3%) |
| Sept 2012 | - | $1.84 M(+1.5%) |
| June 2012 | - | $1.82 M(-10.1%) |
| Mar 2012 | $2.02 M(+60.0%) | $2.02 M(+17.1%) |
| Dec 2011 | - | $1.73 M(+5.9%) |
| Sept 2011 | - | $1.63 M(+28.8%) |
| June 2011 | - | $1.27 M(+0.2%) |
| Mar 2011 | $1.26 M(-19.0%) | $1.26 M(+0.7%) |
| Dec 2010 | - | $1.25 M(-29.7%) |
| Sept 2010 | - | $1.78 M(+8.3%) |
| June 2010 | - | $1.65 M(+5.5%) |
| Mar 2010 | $1.56 M | $1.56 M(-11.4%) |
| Dec 2009 | - | $1.76 M(+8.2%) |
| Sept 2009 | - | $1.63 M(+23.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $1.32 M(+480.2%) |
| Mar 2009 | - | $227.00 K(+216.2%) |
| Dec 2008 | $71.80 K(>+9900.0%) | $71.80 K(+46.5%) |
| Sept 2008 | - | $49.00 K(+113.0%) |
| June 2008 | - | $23.00 K(-58.2%) |
| Mar 2008 | - | $55.00 K(>+9900.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $16.00 K(+23.1%) |
| June 2007 | - | $13.00 K(-71.1%) |
| Mar 2007 | - | $45.00 K(-74.3%) |
| Dec 2006 | $174.80 K(-90.0%) | $174.80 K(-87.3%) |
| Sept 2006 | - | $1.37 M(-15.0%) |
| June 2006 | - | $1.62 M(-0.8%) |
| Mar 2006 | - | $1.63 M(-6.6%) |
| Dec 2005 | $1.74 M(+3.1%) | $1.74 M(-2.1%) |
| Sept 2005 | - | $1.78 M(+25.8%) |
| June 2005 | - | $1.42 M(+0.8%) |
| Mar 2005 | - | $1.41 M(-17.0%) |
| Dec 2004 | $1.69 M(-11.3%) | $1.69 M(-7.6%) |
| Sept 2004 | - | $1.83 M(+1.7%) |
| June 2004 | - | $1.80 M(-8.8%) |
| Mar 2004 | - | $1.97 M(+3.4%) |
| Dec 2003 | $1.91 M(-4.8%) | $1.91 M(+40.3%) |
| Sept 2003 | - | $1.36 M(-5.4%) |
| June 2003 | - | $1.44 M(+22.1%) |
| Mar 2003 | - | $1.18 M(-41.3%) |
| Dec 2002 | $2.00 M(+5.9%) | $2.00 M(+86.9%) |
| Sept 2002 | - | $1.07 M(-5.0%) |
| June 2002 | - | $1.13 M(-11.9%) |
| Mar 2002 | - | $1.28 M(-32.3%) |
| Dec 2001 | $1.89 M(+31.2%) | $1.89 M(+136.4%) |
| Sept 2001 | - | $801.00 K(+15.1%) |
| June 2001 | - | $696.00 K(-48.1%) |
| Mar 2001 | - | $1.34 M(-7.0%) |
| Dec 2000 | $1.44 M(+203.8%) | $1.44 M(+174.9%) |
| Sept 2000 | - | $525.00 K(+14.6%) |
| June 2000 | - | $458.00 K(-8.4%) |
| Mar 2000 | - | $500.00 K(+5.3%) |
| Dec 1999 | $475.00 K(-70.3%) | $475.00 K(-5.0%) |
| Sept 1999 | - | $500.00 K(-28.6%) |
| June 1999 | - | $700.00 K(-12.5%) |
| Mar 1999 | - | $800.00 K(-50.0%) |
| Dec 1998 | $1.60 M(+128.6%) | $1.60 M(+300.0%) |
| Sept 1998 | - | $400.00 K(+33.3%) |
| June 1998 | - | $300.00 K(-25.0%) |
| Mar 1998 | - | $400.00 K(-42.9%) |
| Dec 1997 | $700.00 K(+133.3%) | $700.00 K(+250.0%) |
| Sept 1997 | - | $200.00 K(+100.0%) |
| June 1997 | - | $100.00 K(-50.0%) |
| Mar 1997 | - | $200.00 K(-33.3%) |
| Dec 1996 | $300.00 K(+50.0%) | $300.00 K(+200.0%) |
| Sept 1996 | - | $100.00 K(-50.0%) |
| June 1996 | - | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K(-50.0%) |
| Dec 1995 | $200.00 K | $200.00 K(+100.0%) |
| Sept 1995 | - | $100.00 K(-80.0%) |
| June 1995 | - | $500.00 K |
FAQ
- What is DMK Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals annual accounts payable year-on-year change?
- What is DMK Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for DMK Pharmaceuticals?
- What is DMK Pharmaceuticals quarterly accounts payable year-on-year change?
What is DMK Pharmaceuticals annual accounts payable?
The current annual accounts payable of DMK is $7.94 M
What is the all time high annual accounts payable for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high annual accounts payable is $7.94 M
What is DMK Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, DMK annual accounts payable has changed by +$4.18 M (+111.44%)
What is DMK Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of DMK is $9.97 M
What is the all time high quarterly accounts payable for DMK Pharmaceuticals?
DMK Pharmaceuticals all-time high quarterly accounts payable is $11.37 M
What is DMK Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, DMK quarterly accounts payable has changed by +$4.68 M (+88.26%)